Artículos de revistas sobre el tema "CDDOBA"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "CDDOBA".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Konopleva, Marina, Ismael Samudio, Twee Tsao, Steven M. Kornblau, Yue-Xi Shi, Teresa McQueen, Rooha Contractor et al. "Mechanisms and Activity of PPARγ-Active Triterpenoids CDDO and CDDO-Me in Leukemias." Blood 106, n.º 11 (16 de noviembre de 2005): 2460. http://dx.doi.org/10.1182/blood.v106.11.2460.2460.
Texto completoSetiawan, A. M., A. A. Syafrianno, R. Rahmat y Supari. "High-Resolution North Sulawesi Drought Hazzard Mapping Based on Consecutive Dry Days (CDD)". IOP Conference Series: Earth and Environmental Science 893, n.º 1 (1 de noviembre de 2021): 012018. http://dx.doi.org/10.1088/1755-1315/893/1/012018.
Texto completoPanwar, Kuldeep, Dinesh Prasad, Mayank Srivastava y Zainab Haseeb. "New Current Mode Lossy Integrator Employing CDDITA". Circuits and Systems 09, n.º 08 (2018): 117–23. http://dx.doi.org/10.4236/cs.2018.98012.
Texto completoWang, Yongping, Weston W. Porter, Nanjoo Suh, Tadashi Honda, Gordon W. Gribble, Lisa M. Leesnitzer, Kelli D. Plunket et al. "A Synthetic Triterpenoid, 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid (CDDO), Is a Ligand for the Peroxisome Proliferator-Activated Receptor γ". Molecular Endocrinology 14, n.º 10 (1 de octubre de 2000): 1550–56. http://dx.doi.org/10.1210/mend.14.10.0545.
Texto completoIkeda, Takashi, Yukiko Nakata, Fumihiko Kimura, Ken Sato, Kenneth Anderson, Kazuo Motoyoshi, Michael Sporn y Donald Kufe. "Induction of redox imbalance and apoptosis in multiple myeloma cells by the novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid". Molecular Cancer Therapeutics 3, n.º 1 (1 de enero de 2004): 39–45. http://dx.doi.org/10.1158/1535-7163.39.3.1.
Texto completoKoh, Eun-Young, Keun-Sik Kim, Hee-Bin Park, Jong-Seok Kim y Pyung-Hwan Kim. "Active Targeting of Versatile Nanocomplex Using the Novel Biomarker of Breast Cancer Stem Cells". International Journal of Molecular Sciences 24, n.º 1 (30 de diciembre de 2022): 685. http://dx.doi.org/10.3390/ijms24010685.
Texto completoKress, Christina L., Marina Konopleva, Maryla Krajewska, Vanesa Martinez-Garcia, Sophie Lefebvre, Marc L. Hyer, Teresa McQueen, Michael Andreeff, John C. Reed y Juan Zapata. "Triterpenoids Display Single Agent Activity in a Mouse Model of CLL/SBL." Blood 108, n.º 11 (16 de noviembre de 2006): 2530. http://dx.doi.org/10.1182/blood.v108.11.2530.2530.
Texto completoBrookes, Paul, Andrew Tompkins, Kimberly Morse, Shannon Hilchey, Suhail Salim, Denise Ray, Richard Phipps y Steven H. Bernstein. "The Triterpenoids 2-cyano-3,12-dioxooleana-1,9-dien-28-oic Acid (CDDO) and Their Imidazole (CDDO-Im) and Dinitrile Derivatives (DI-CDDO) Elicit Apoptosis through a Novel Mitochondrial Pathway." Blood 106, n.º 11 (16 de noviembre de 2005): 2426. http://dx.doi.org/10.1182/blood.v106.11.2426.2426.
Texto completoElsawa, Sherine F., Anne J. Novak, Marina Konopleva, Michael Andreeff, Thomas E. Witzig y Stephen M. Ansell. "Preferential Inhibition of Malignant Cell Growth by CDDO in Waldenström Macroglobulinemia." Blood 108, n.º 11 (16 de noviembre de 2006): 2528. http://dx.doi.org/10.1182/blood.v108.11.2528.2528.
Texto completoKonopleva, Marina, Twee Tsao, Peter Ruvolo, Irina Stiouf, Zeev Estrov, Clinton E. Leysath, Shourong Zhao et al. "Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia". Blood 99, n.º 1 (1 de enero de 2002): 326–35. http://dx.doi.org/10.1182/blood.v99.1.326.
Texto completoKim, Ji-Eun, Hana Park y Tae-Cheon Kang. "CDDO-Me Distinctly Regulates Regional Specific Astroglial Responses to Status Epilepticus via ERK1/2-Nrf2, PTEN-PI3K-AKT and NFκB Signaling Pathways". Antioxidants 9, n.º 10 (21 de octubre de 2020): 1026. http://dx.doi.org/10.3390/antiox9101026.
Texto completoChauhan, Dharminder, Guilan Li, Klaus Podar, Teru Hideshima, Reshma Shringarpure, Laurence Catley, Constantine Mitsiades et al. "The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti–multiple myeloma (MM) activity and overcome bortezomib resistance". Blood 103, n.º 8 (15 de abril de 2004): 3158–66. http://dx.doi.org/10.1182/blood-2003-08-2873.
Texto completoRay, Denise, Kimberly Morse, Shannon Hilchey, Tatiana Garcia, Raymond Felgar, Sanjay Maggirwar, Richard Phipps y Steven H. Bernstein. "The Novel Triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic Acid (CDDO) Induces Apoptosis of Human Diffuse Large B-Cell Lymphoma Cells (DLCL) through a Peroxisome Proliferator-Activated Receptor γ (PPARγ) Independent Pathway Which Is Enhanced by NFκB Inhibition." Blood 106, n.º 11 (16 de noviembre de 2005): 2425. http://dx.doi.org/10.1182/blood.v106.11.2425.2425.
Texto completoWelniak, Lisbeth A., Salif Harouna, David Prosser, Erik Ames, Colin Meyer y William J. Murphy. "The Antioxidant Inflammation Modulator, CDDO-Me Promotes Myelopoiesis in Mice." Blood 112, n.º 11 (16 de noviembre de 2008): 2335. http://dx.doi.org/10.1182/blood.v112.11.2335.2335.
Texto completoZapata, Juan M., Christina L. Kress, Marina Konopleva, Maryla Krajewska, Mark Hyer, Teresa McQueen y Michael Andreeff. "CDDO and CDDO-Im Reduce Tumor Burden in a Transgenic Mouse Model of CLL." Blood 104, n.º 11 (16 de noviembre de 2004): 3477. http://dx.doi.org/10.1182/blood.v104.11.3477.3477.
Texto completoChang, Chih-Hui, Hung-Pei Tsai, Shih-Hsun Kuo, Joon-Khim Loh, Chien-Ju Lin, Chih-Lung Lin y Aij-Lie Kwan. "Synthetic Triterpenoid CDDO-Me Inhibits Proliferation, Migration, and Invasion in GBM8401 and GBM8901". International Surgery 104, n.º 3-4 (1 de marzo de 2020): 90–98. http://dx.doi.org/10.9738/intsurg-d-20-00005.1.
Texto completoKoschmieder, Steffen, Francesco D'Alò, Hanna Radomska, Christine Schöneich, Ji Suk Chang, Marina Konopleva, Susumu Kobayashi et al. "CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer–binding protein alpha". Blood 110, n.º 10 (15 de noviembre de 2007): 3695–705. http://dx.doi.org/10.1182/blood-2006-11-058941.
Texto completoBorella, Rebecca, Luca Forti, Lara Gibellini, Anna De Gaetano, Sara De Biasi, Milena Nasi, Andrea Cossarizza y Marcello Pinti. "Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids". Molecules 24, n.º 22 (13 de noviembre de 2019): 4097. http://dx.doi.org/10.3390/molecules24224097.
Texto completoKonopleva, Marina, Peter Ruvolo, Rooha Contractor, Svitlana Kurinna, Yue-Xi Shi, Teresa McQueen, Michele Milella y Michael Andreeff. "Triterpenoid Methyl-CDDO Is a Potent Inducer of Apoptosis in CD34+ AML Progenitor Cells Via Activation of SAPK Pathways and Inhibition of MAPK Cascades." Blood 104, n.º 11 (16 de noviembre de 2004): 2533. http://dx.doi.org/10.1182/blood.v104.11.2533.2533.
Texto completoKim, Min-Ju, Hana Park, Seo-Hyeon Choi, Min-Jeong Kong, Ji-Eun Kim y Tae-Cheon Kang. "CDDO-Me Attenuates Vasogenic Edema and Astroglial Death by Regulating NF-κB p65 Phosphorylations and Nrf2 Expression Following Status Epilepticus". International Journal of Molecular Sciences 20, n.º 19 (30 de septiembre de 2019): 4862. http://dx.doi.org/10.3390/ijms20194862.
Texto completoPioli, Patricia Ann, Michael S. Ball, Rajan Bhandari, Gretel Maria Torres Santiesteban, Viktor Martyanov, Mohamed Eltanbouly, Michael L. Whitfield y Karen Liby. "Redirecting Immune Activation in the Tumor Microenvironment of Estrogen Receptor Negative Breast Cancer". Journal of Immunology 204, n.º 1_Supplement (1 de mayo de 2020): 242.37. http://dx.doi.org/10.4049/jimmunol.204.supp.242.37.
Texto completoTsai, Tai-Hsin, Cheng-Yu Tsai, Sin-Hua Moi, Chieh-Hsin Wu, Kuan-Ting Lee, Yi-Chiang Hsu y Yu-Feng Su. "A Novel Synthetic Oleanolic Acid Derivative Inhibits Glioma Cell Proliferation by Regulating Cell Cycle G2/M Arrest". Pharmaceuticals 16, n.º 5 (24 de abril de 2023): 642. http://dx.doi.org/10.3390/ph16050642.
Texto completoKoschmieder, Steffen, Francesco D′Alo′, Hanna Radomska, Susumu Kobayashi, Elena Levantini, Nanjoo Suh, Michael B. Sporn et al. "CDDO Increases Translation of CCAAT Enhancer Binding Protein alpha To Induce Granulocytic Differentiation." Blood 106, n.º 11 (16 de noviembre de 2005): 2458. http://dx.doi.org/10.1182/blood.v106.11.2458.2458.
Texto completoMurphy, William J., Olga Frolova, Marina Konopleva, Michael Andreeff, Weihong Ma, Danice Wilkins, Lisbeth A. Welniak y Kai Sun. "Immunomodulatory Effects of the Triterpenoid CDDO after Allogeneic Bone Marrow Transplantation in Mice: Reduction of Acute Graft-Versus-Host Disease Lethality." Blood 106, n.º 11 (16 de noviembre de 2005): 1316. http://dx.doi.org/10.1182/blood.v106.11.1316.1316.
Texto completoKurosaki, Yoshifumi, Akemi Imoto, Fumitaka Kawakami, Motoshi Ouchi, Asuka Morita, Masanori Yokoba, Tsuneo Takenaka et al. "In vitro study on effect of bardoxolone methyl on cisplatin-induced cellular senescence in human proximal tubular cells". Molecular and Cellular Biochemistry 477, n.º 3 (1 de enero de 2022): 689–99. http://dx.doi.org/10.1007/s11010-021-04295-y.
Texto completoSamudio, Ismael, Marina Konopleva, Numsen Hail, Yue-Xi Shi, Teresa McQueen, Timothy Hsu, Randall Evans et al. "2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) Directly Targets Mitochondrial Glutathione to Induce Apoptosis in Pancreatic Cancer". Journal of Biological Chemistry 280, n.º 43 (23 de agosto de 2005): 36273–82. http://dx.doi.org/10.1074/jbc.m507518200.
Texto completoHuang, Youqun, Mulin Ye, Chunlin Wang, Zhenfen Wang y Weiping Zhou. "Protective effect of CDDO-imidazolide against intestinal ischemia/reperfusion injury in mice". European Journal of Inflammation 16 (enero de 2018): 205873921880268. http://dx.doi.org/10.1177/2058739218802681.
Texto completoLiu, Caihong y Qiang Liu. "Community Detection Based on Differential Evolution Using Modularity Density". Information 9, n.º 9 (30 de agosto de 2018): 218. http://dx.doi.org/10.3390/info9090218.
Texto completoSamudio, Ismael, Marina Konopleva, Helene Pelicano, Peng Huang, Olga Frolova, William Bornmann, Yun-ming Ying, Randall Evans y Michael Andreeff. "A Novel Mechanism of Action of Methyl-2-cyano-3,12 dioxoolean-1,9 diene-28-oate (CDDO-Me): Direct Permeabilization of the Inner Mitochondrial Membrane To Inhibit Electron Transport and Induce Apoptosis." Blood 106, n.º 11 (16 de noviembre de 2005): 4462. http://dx.doi.org/10.1182/blood.v106.11.4462.4462.
Texto completoKim, Park, Choi, Kong y Kang. "CDDO-Me Selectively Attenuates CA1 Neuronal Death Induced by Status Epilepticus via Facilitating Mitochondrial Fission Independent of LONP1". Cells 8, n.º 8 (5 de agosto de 2019): 833. http://dx.doi.org/10.3390/cells8080833.
Texto completoHolkova, B., S. Kummar, P. Glauber, A. Chen, J. M. Strong, R. J. Parker, J. Collins, A. J. Murgo, J. H. Doroshow y M. E. Gutierrez. "A phase I study of 2-cyano-3, 12 dioxoolean-1, 9-dien-28-oic acid (CDDO) in advance solid tumors". Journal of Clinical Oncology 25, n.º 18_suppl (20 de junio de 2007): 14137. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.14137.
Texto completoAmeen, Azad A., Tarik A. Rashid y Shavan Askar. "CDDO–HS: Child Drawing Development Optimization–Harmony Search Algorithm". Applied Sciences 13, n.º 9 (8 de mayo de 2023): 5795. http://dx.doi.org/10.3390/app13095795.
Texto completoGee, Min Sung, Sung-Bae Kang, Namkwon Kim, Jiyoon Choi, Nam-Jung Kim, Bum-Joon Kim, Kyung-Soo Inn y Jong Kil Lee. "Bardoxolone Methyl Suppresses Hepatitis B Virus Large Surface Protein Variant W4P-Related Carcinogenesis and Hepatocellular Carcinoma Cell Proliferation Via the Inhibition of Signal Transducer and Activator of Transcription 3 Signaling". Pharmacology 102, n.º 1-2 (2018): 105–13. http://dx.doi.org/10.1159/000489998.
Texto completoBernstein, Steven H., Sundararajan Venkatesh, Min Li, Jae Lee, Bin Lu, Shannon P. Hilchey, Kimberly M. Morse et al. "The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives". Blood 119, n.º 14 (5 de abril de 2012): 3321–29. http://dx.doi.org/10.1182/blood-2011-02-340075.
Texto completoPrasad, Dinesh, Kuldeep Panwar, D. R. Bhaskar y Mayank Srivastava. "CDDITA-Based Voltage-Mode First Order All Pass Filter Configuration". Circuits and Systems 06, n.º 11 (2015): 252–56. http://dx.doi.org/10.4236/cs.2015.611025.
Texto completoGleixner, Karoline V., Harald Herrmann, Katharina Blatt, Winfried F. Pickl, Marina Konopleva, Gahininath Y. Bharate, Michael Andreeff, Hiroshi Maeda y Peter Valent. "The Heat Shock Protein 32 (Hsp32)/HO-1-Targeting Drug SMA-ZnPP and the Triterpenoid CDDO-Me Exert Synergistic Growth-Inhibitory Effects on TKI-Resistant Leukemic Cells in Ph+ CML". Blood 118, n.º 21 (18 de noviembre de 2011): 4414. http://dx.doi.org/10.1182/blood.v118.21.4414.4414.
Texto completoKhurana, Namrata, Partha K. Chandra, Hogyoung Kim, Asim B. Abdel-Mageed, Debasis Mondal y Suresh C. Sikka. "Bardoxolone-Methyl (CDDO-Me) Suppresses Androgen Receptor and Its Splice-Variant AR-V7 and Enhances Efficacy of Enzalutamide in Prostate Cancer Cells". Antioxidants 9, n.º 1 (12 de enero de 2020): 68. http://dx.doi.org/10.3390/antiox9010068.
Texto completoLin, Xun, Suzanne Tawch, Stephen Gaudino, Suyasha Roy, Patricia Castillo, Waleed Abdel Wahab Elsegeiny, Nobunao Wakabayashi et al. "Nrf2 differentially regulates pro- and anti-inflammatory function of Th17 cells through RORγT, SOD3 and Ahr". Journal of Immunology 204, n.º 1_Supplement (1 de mayo de 2020): 59.34. http://dx.doi.org/10.4049/jimmunol.204.supp.59.34.
Texto completoBernstein, Steven H., Bin Lin, Shannon Hilchey, N. Villaluna, L. Chen, K. Madura, Kim Morse et al. "The Triterpenoid 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic Acid and Its Derivatives Inhibit Mitochondrial Lon Protease Activity: A Potential Novel Pathway for the Induction of Lymphoma Cell Death." Blood 114, n.º 22 (20 de noviembre de 2009): 414. http://dx.doi.org/10.1182/blood.v114.22.414.414.
Texto completoSuh, N., S. Paul, H. J. Lee, T. Yoon, N. Shah, A. I. Son, A. H. Reddi, D. Medici y M. B. Sporn. "RETRACTED: Synthetic triterpenoids, CDDO-Imidazolide and CDDO-Ethyl amide, induce chondrogenesis". Osteoarthritis and Cartilage 20, n.º 5 (mayo de 2012): 446–50. http://dx.doi.org/10.1016/j.joca.2012.01.018.
Texto completoMoerland, Jess Ann y Karen T. Liby. "Abstract 3534: The triterpenoid CDDO-Me redirects macrophage polarization and decreases tumor burden in a preclinical model of NSCLC". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 3534. http://dx.doi.org/10.1158/1538-7445.am2022-3534.
Texto completoKim, Ji-Eun, Hana Park, Ji-Eun Lee y Tae-Cheon Kang. "CDDO-Me Inhibits Microglial Activation and Monocyte Infiltration by Abrogating NFκB- and p38 MAPK-Mediated Signaling Pathways Following Status Epilepticus". Cells 9, n.º 5 (1 de mayo de 2020): 1123. http://dx.doi.org/10.3390/cells9051123.
Texto completoAmirova, Kristiana M., Petya A. Dimitrova, Milena N. Leseva, Ivanka K. Koycheva, Albena T. Dinkova-Kostova y Milen I. Georgiev. "The Triterpenoid Nrf2 Activator, CDDO-Me, Decreases Neutrophil Senescence in a Murine Model of Joint Damage". International Journal of Molecular Sciences 24, n.º 10 (15 de mayo de 2023): 8775. http://dx.doi.org/10.3390/ijms24108775.
Texto completoSiracusa, Rosalba, Ramona D’Amico, Marika Cordaro, Alessio Filippo Peritore, Tiziana Genovese, Enrico Gugliandolo, Rosalia Crupi et al. "The Methyl Ester of 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic Acid Reduces Endometrial Lesions Development by Modulating the NFkB and Nrf2 Pathways". International Journal of Molecular Sciences 22, n.º 8 (13 de abril de 2021): 3991. http://dx.doi.org/10.3390/ijms22083991.
Texto completoPedersen, Irene M., Shinichi Kitada, Aaron Schimmer, Youngsoo Kim, Juan M. Zapata, Lula Charboneau, Laura Rassenti et al. "The triterpenoid CDDO induces apoptosis in refractory CLL B cells". Blood 100, n.º 8 (15 de octubre de 2002): 2965–72. http://dx.doi.org/10.1182/blood-2002-04-1174.
Texto completoLin, Xun, Stephen Gaudino, Jay Kolls y Pawan Kumar. "Nrf2 selectively regulates IL-22 and IL-17A production in Th17 cells". Journal of Immunology 202, n.º 1_Supplement (1 de mayo de 2019): 181.7. http://dx.doi.org/10.4049/jimmunol.202.supp.181.7.
Texto completoCasares, Laura, Rita Moreno, Kevin X. Ali, Maureen Higgins, Sharadha Dayalan Naidu, Graham Neill, Lena Cassin et al. "The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclear exclusion of BACH1 impairing its activity". Redox Biology 51 (mayo de 2022): 102291. http://dx.doi.org/10.1016/j.redox.2022.102291.
Texto completoMoerland, Jess Ann y Karen T. Liby. "Abstract 5176: CDDO-methyl ester redirects macrophage polarization and reduces lung tumor burden in a Nrf2-dependent manner". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 5176. http://dx.doi.org/10.1158/1538-7445.am2023-5176.
Texto completoKim, Ji-Eun y Tae-Cheon Kang. "CDDO-Me Attenuates Astroglial Autophagy via Nrf2-, ERK1/2-SP1- and Src-CK2-PTEN-PI3K/AKT-Mediated Signaling Pathways in the Hippocampus of Chronic Epilepsy Rats". Antioxidants 10, n.º 5 (23 de abril de 2021): 655. http://dx.doi.org/10.3390/antiox10050655.
Texto completoSantiesteban, Gretel Maria Torres, Tamer Shabaneh, Rajan Bhandari, Karen Liby, Mary Jo Turk y Patricia Pioli. "CDDO-Me Redirects Macrophage Activation". Journal of Immunology 202, n.º 1_Supplement (1 de mayo de 2019): 135.17. http://dx.doi.org/10.4049/jimmunol.202.supp.135.17.
Texto completo